Form 10-Q Anthera Pharmaceuticals For: Mar 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- Wall St futures rise as Treasury yields cool, oil slips
- Oil slips as Mideast exports, G7 stockpile ease supply concerns
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
- HubSpot to cut 7% of workforce in restructuring plan
- Citi cuts investment banking analyst program to two years - Bloomberg
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Nasdaq notches record high close as investors focus on earnings
- Francis Halzen wins Nobel Physics Prize for Antarctic 'ghost particle' hunt
Anthera Pharma (ANTH) Tops Q1 EPS by 3c
May 11, 2015 5:31 PM EDTAnthera Pharma (NASDAQ: ANTH) reported Q1 EPS of ($0.28), $0.03 better than the analyst estimate of ($0.31).
For earnings history and earnings-related data on Anthera Pharma (ANTH) click here.
... More


